Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

IPSEN

  • FDA Approval
  • March 21, 2025, 08:44 UTC
  • 44

FDA approve ODEVIXIBAT

Comment Full text

HIKMA

  • FDA Approval
  • March 21, 2025, 08:44 UTC
  • 44

FDA approve TETRACYCLINE HYDROCHLORIDE

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • March 21, 2025, 08:44 UTC
  • 43

FDA approve FINASTERIDE; TADALAFIL

Comment Full text

CHARTWELL

  • FDA Approval
  • March 21, 2025, 08:44 UTC
  • 49

FDA approve ALLOPURINOL

Comment Full text

ZYDUS PHARMS USA INC

  • FDA Approval
  • March 21, 2025, 08:44 UTC
  • 44

FDA approve CARVEDILOL

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • March 21, 2025, 04:29 UTC
  • 41

FDA approve PERPHENAZINE

Comment Full text

AUROBINDO PHARMA USA

  • FDA Approval
  • March 20, 2025, 08:44 UTC
  • 45

FDA approve LAMIVUDINE

Comment Full text

SUN PHARM

  • FDA Approval
  • March 20, 2025, 08:44 UTC
  • 43

FDA approve DEFLAZACORT

Comment Full text

SAGENT

  • FDA Approval
  • March 20, 2025, 08:44 UTC
  • 39

FDA approve PROCHLORPERAZINE EDISYLATE

Comment Full text

GRAVITI PHARMS

  • FDA Approval
  • March 20, 2025, 08:44 UTC
  • 49

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text
  • Previous
  • 76
  • 77
  • 78
  • 79
  • 80
  • Next

Search

News categories

  • Technical Exchange News(9514)
  • Event(407)
  • SEC News(156049)
  • FDA Approval(8914)
  • Company Report(721)
  • Business News(105959)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin